Modulation of vascular development and injury by angiotensin II

Cardiovascular Research

Volumn 41, Issue 3, 1999, Pages 689-700

  Hutchinson, Howard G ^a,b   Hein, Lutz ^a,c   Fujinaga, Masahiko ^a,d   Pratt, Richard E ^e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Developmental biology; Growth control; Neointima; Protein coupled receptors; Quantitative RT PCR; Smooth muscle

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; DNA; LOSARTAN POTASSIUM; MESSENGER RNA;

ADOLESCENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL GROWTH; DEVELOPMENT; DNA SYNTHESIS; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; GROWTH REGULATION; INTIMA; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; BALLOON DILATATION; CAROTID ARTERIES; DNA; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; IMIDAZOLES; LOSARTAN; MALE; MUSCLE, SMOOTH, VASCULAR; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0344573812     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00267-3     Document Type: Article

References (45)

1. Murphy T.J., Alexander R.W., Griendling K.K., Runge M.S., Bernstein K.E. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 351:1991;233-236.
2. Sasaki K., Yamano Y., Bardhan S.et al. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 351:1991;230-233.
3. Sasamura H., Hein L., Krieger J.E.et al. Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun. 185:1992;253-259.
4. Elton T.S., Stephan C.C., Taylor G.R.et al. Isolation of two distinct type I angiotensin II receptor genes. Biochem Biophys Res Commun. 184:1992;1067-1073.
5. Sandberg K., Ji H., Clark A.J., Shapira H., Catt K.J. Cloning and expression of a novel angiotensin II receptor subtype. J Biol Chem. 267:1992;9455-9458.
6. Whitebread S., Mele M., Kamber B., de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun. 163:1989;284-291.
7. Chiu A.T., Herblin W.F., McCall D.E.et al. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun. 165:1989;196-203.
8. Mukoyama M., Nakajima M., Horiuchi M.et al. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 268:1993;24539-24542.
9. Nakajima M., Mukoyama M., Pratt R.E., Horiuchi M., Dzau V.J. Cloning of cDNA and analysis of the gene for mouse angiotensin type 2 receptor. Biochem Biophys Res Commun. 197:1993;393-399.
10. Kambayashi Y., Bardhan S., Takahashi K.et al. Molecular cloning of novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 268:1993;24543-24546.
11. 2 receptors in the developing rat fetus. J Clin Invest. 88:1991;921-933.
12. Viswanathan M., Tsutsumi K., Correa F.M., Saavedra J.M. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun. 179:1991;1361-1367.
13. Dzau V.J., Gibbons G.H., Pratt R.E. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension. 18:1991;II100-II105.
14. Rakugi H., Wang D.S., Dzau V.J., Pratt R.E. Potential importance of tissue angiotensin converting enzyme inhibition in preventing neointima formation. Circulation. 90:1994;449-455.
15. Daemen M.J.A.P., Lombardi D.M., Bosman F.T., Schwartz S.M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 68:1991;450-456.
16. Powell J.S., Clozel J.P., Muller R.K.et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 245:1989;186-188.
17. 1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol. 139:1991;1291-1296.
18. Farhy R.D., Carretero O.A., Ho K.L., Scicli A.G. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointimal proliferation. Circ Res. 72:1993;1202-1210.
19. Rakugi H., Wang D., Giachelli C.M.et al. Developmentally regulated production of angiotensin converting enzyme in cultured rat vascular smooth muscle cells. Clin Res. 40:1992;146A.
20. Morrell N.W., Grieshaber S.S., Danilov S.M., Majack R.A., Stenmark K.R. Developmental regulation of angiotensin converting enzyme and angiotensin type 1 receptor in the rat pulmonary circulation. Am J Resp Cell Mol Biol. 14(6):1996;526-537.
21. Tufro-McReddie A., Romano L.M., Harris J.M., Ferder L., Gomez R.A. Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol. 269(1 Pt 2):1995;F110-F115.
22. Jones C., Millan M.A., Naftolin F., Aguilera G. Characterization of angiotensin II receptors in the rat fetus. Peptides. 10:1989;459-463.
23. 1 receptor: gain of function approach using in vivo gene transfer. Proc Natl Acad Sci USA. 92:1995;10663-10667.
24. Schwartz S.M., Foy L., Bowen-Pope D.R., Ross R. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol. 136:1990;1417-1428.
25. Majesky M.W., Giachelli C.M., Reidy M.A., Schwartz S.M. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 71:1992;759-768.
26. Kocher O., Gabbiani F., Gabbiani G.et al. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab Invest. 66:1991;459-470.
27. Rakugi H., Kim D.K., Krieger J.E.et al. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest. 93:1994;339-346.
28. Kim D., Zhang L., Dzau V.J., Pratt R.E. H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells following injury. J Clin Invest. 93:1994;355-360.
29. Janiak P., Pillon A., Prost J.-F., Vilaine J.-P. Role of angiotensin subtype 2 receptors in neointima formation after vascular injury. Hypertension. 20:1992;737-745.
30. Matsubara H., Kanasaki M., Murasawa S.et al. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest. 93:1994;1592-1601.
31. Fort P., Marty L., Piechaczyk M.et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1985;1431-1442.
32. Ginzburg I., Teichman A., Griffin W.S., Littauer U.Z. Differential expression of alpha-tubulin mRNA in rat cerebellum as revealed by in situ hybridization. FEBS Lett. 194:1986;161-164.
33. Suzuki J.H., Matsubara M., Urakami M., Inada M. Rat angiotensin II (IA) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 73:1993;439-447.
34. Heuvel J.P.V., Tyson F.L., Bell D.A. Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques. 14:1993;395-398.
35. Cook C.L., Weiser M.C., Schwartz P.E., Jones C.L., Majack R.A. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ Res. 74:1994;189-196.
36. 1 receptors in neointima of rat aorta. J Clin Invest. 90:1992;1707-1712.
37. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 95:1995;651-657.
38. Hilgers K.F., Reddi V., Krege J.H., Smithies O., Gomez R.A. Aberrant renal vascular morphology and renin expression in mutant mice lacking angiotensin-converting enzyme. Hypertension. 29(1 Pt 2):1997;216-221.
39. Nagata M., Tanimoto K., Fukamizu A.et al. Nephrogenesis and renovascular development in angiotensinogen-deficient mice. Lab Invest. 75(5):1996;745-753.
40. Ito M., Oliverio M.I., Mannon P.J.et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA. 92(8):1995;3521-3525.
41. Chen X., Li W., Yoshida H.et al. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol. 272(3 Pt 2):1997;F299-F304.
42. Tsuchida S., Matsusaka T., Chen X.et al. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest. 101(4):1998;755-760.
43. Hein L., Barsh G.S., Pratt R.E., Dzau V.J., Kobilka B.K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature. 377(6551):1995;744-747.
44. Akishita M, Horiuchi M, Yamada H, Zhang L, Dzau, VJ. Accentuated vascular proliferation and altered remodeling after injury in mice lacking angiotensin type 2 receptor. Circulation 1997;96:I-547 (abstract).
45. 2 receptor in PC12W cells. Regul Pept. 44:1993;207-213.